| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/26/1997 | WO1997022587A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/26/1997 | WO1997022343A1 USE OF α,α-DIPHENYLACETIC ACID-4-(N-METHYL-PIPERIDYL)ESTER AS ANTI-SPASMODIC |
| 06/26/1997 | WO1997022341A1 Endothelin receptor antagonists |
| 06/26/1997 | WO1997022340A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 06/26/1997 | WO1997022339A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 06/26/1997 | WO1997022251A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | CA2244396A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 06/26/1997 | CA2241004A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/25/1997 | EP0780388A1 5HT1Dalpha and 5HT2A ligands |
| 06/25/1997 | EP0780379A1 A 4-imidazolidinone derivative and its use as NMDA receptor agonist |
| 06/25/1997 | EP0780369A1 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents |
| 06/25/1997 | EP0780123A1 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0723444B1 Levobupivacaine useful for managing chronic pain |
| 06/25/1997 | EP0707478A4 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
| 06/25/1997 | CN1152920A Palladium catalyzed ring closure of triazolyl tryptamine |
| 06/25/1997 | CN1152919A Triazole compounds and their use as dopamine-D3-ligands |
| 06/25/1997 | CN1152918A Novel amido quinoxaline diones, their production and use |
| 06/25/1997 | CN1152917A Substituted pryimidine compounds and their use |
| 06/25/1997 | CN1152915A Quinoline derivatives as leukotriene antagonists |
| 06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
| 06/25/1997 | CN1152873A New pharmaceutical preparationf or pain management |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152870A Use of heterocyclic compounds as dopamines-D3 ligands |
| 06/25/1997 | CN1152574A Crystalline hydrochloride of (R)-(-)2{N-4£4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl|-aminomethyl}-chroman |
| 06/25/1997 | CN1152573A Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 06/25/1997 | CN1152572A New heterocyclic tertiary amines, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | CN1152434A Oral preparation of S(+)1,8-diethyl-1,3,4,9-tetrahydropyrano (3,4-b) indole-1-acetic acid |
| 06/24/1997 | US5641807 Administering 3-amino-5-carbamoylchromans |
| 06/24/1997 | US5641801 Method of reducing the period before the onset of sleep |
| 06/24/1997 | US5641798 Bicyclic compounds and their use as excitatory amino acid receptor antagonists |
| 06/24/1997 | US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles |
| 06/24/1997 | US5641786 Quinuclidine derivatives |
| 06/24/1997 | US5641785 Antidepressants, nervous system disorders |
| 06/24/1997 | US5641779 Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641775 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists |
| 06/24/1997 | US5641772 Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/19/1997 | WO1997021731A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | WO1997021710A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021709A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 06/19/1997 | WO1997021692A1 Novel compounds and methods for treating multiple sclerosis |
| 06/19/1997 | WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | WO1997021684A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021676A1 Azetidinone compounds for the treatment of atherosclerosis |
| 06/19/1997 | WO1997021675A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| 06/19/1997 | WO1997021670A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 06/19/1997 | WO1997021668A1 Phenylacetamide derivatives |
| 06/19/1997 | WO1997021449A1 Method for effecting changes in the central nervous system by administration of igf-i or igf-ii |
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021432A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock |
| 06/19/1997 | WO1997021416A2 Glycoconjugates of opiated substances |
| 06/19/1997 | DE19546452A1 Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel New Phenylamidinderivate, processes for their Herstelung and their use as medicaments |
| 06/19/1997 | CA2240279A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | CA2240115A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2239293A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/19/1997 | CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | CA2212371A1 Novel compounds and methods for treating multiple sclerosis |
| 06/19/1997 | CA2211596A1 Glycoconjugates of opiated substances |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779284A1 Novel 2-naphthamide derivatives and their use in therapy as D3 receptor agonists |
| 06/18/1997 | EP0779282A1 Thiomorpholinone compounds for treating multiple sclerosis |
| 06/18/1997 | EP0779281A1 Isoxazoles |
| 06/18/1997 | EP0778836A1 Substituted 9-alkyladenines |
| 06/18/1997 | EP0778835A1 7-azabicyclo 2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
| 06/18/1997 | EP0778834A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 06/18/1997 | EP0778833A1 Endothelin receptor antagonists |
| 06/18/1997 | EP0778831A1 Morpholine derivatives and their use as therapeutic agents |
| 06/18/1997 | EP0778820A1 Neurotrophic and antiproliferative compounds |
| 06/18/1997 | EP0778775A1 Cosolvent parenteral formulation of tirilazad |
| 06/18/1997 | EP0778770A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer |
| 06/18/1997 | EP0778769A1 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 06/18/1997 | EP0778768A1 Formulations and methods for providing prolonged local anesthesia |
| 06/18/1997 | EP0687257B1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 06/18/1997 | EP0538314B1 Indano pyrrolidine carbamates |
| 06/18/1997 | EP0447483B1 Dopamine receptors and genes |
| 06/18/1997 | CN1152314A New agonist compounds |
| 06/18/1997 | CN1152313A Process for preparation of 2-(1-azabicyclo(2,2,2)oct-3-yl)-2,4,5,6-tetrahydro-1H-benz (DE)isoquinolin-1-1one and intermediate product |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1151989A 2-(aminomethyl)-3,4,7,-9-tetrahydro-2H-pyrano-£2,3-e| indol-8-ones and derivatives |
| 06/18/1997 | CN1151986A N-methyl-n-£(1s)-1-phenyl-2-((3s)-3-hydroxypyrrolidin-1-yl) ethyl-2,2-diphenylacetamide |
| 06/18/1997 | CN1035179C New indol derivatives |
| 06/17/1997 | US5639892 Memory enhancing and analgesic 1,2,3,3a,8,8a,-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b] indoles |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639792 No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption |
| 06/17/1997 | US5639784 Administering 3-amino-5-carbamoyl-chromenes and derivatives |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639779 Treatment of different types of headaches |
| 06/17/1997 | US5639778 Indoletetralins having dopaminergic activity |